Amgen’s Repatha linked to fewer heart attacks
Meghana Keshavan is a biotech correspondent at STAT and co-writer of The Readout newsletter. She joined STAT in 2016. She has written about the life sciences industry for more than a decade. Before that, she worked for news outlets like Thomson Reuters, the Detroit Free Press, the Detroit Metro Times…